U.S. Army Medical Research and Development Command: all 153 studies

Page 1 of 2. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress DisorderNot yet recruitingNCT07704762Phase 2
• Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy AdultsRecruitingNCT06205056Phase 1
• Optimizing Volunteer Comfort for Transcranial Electrical Stimulation (TES): An AssessmentEnrolling by invitationNCT04474015Not applicable
• An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran SampleRecruitingNCT04180930
• Phase 2 Safety and Immunogenicity Study of Rift Valley Fever VaccineRecruitingNCT03609398Phase 2
• Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in AdultsNot yet recruitingNCT03531242Phase 2
• Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM SleepRecruitingNCT02945501Not applicable
• Tecovirimat (ST-246) Treatment for Orthopox Virus ExposureAvailableNCT02080767
• Single or Repeat Dose of G03-52-01 in Adult SubjectsCompletedNCT05348993Phase 2Results posted
• Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54CompletedNCT03882528Phase 1Results posted
• Combination HTNV and PUUV DNA VaccineCompletedNCT03718130Phase 1Results posted
• Ascending Doses of Autologous FDP vs FFPCompletedNCT02930226Phase 1Results posted
• Is an Antiplaque Chewing Gum (30 mg) Able to Reduce Dental Plaque in a Healthy Population?CompletedNCT02864901Phase 2Results posted
• An Evaluation of Weekly TafenoquineCompletedNCT02488980Phase 2Results posted
• Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01BCompletedNCT02458092Phase 1Results posted
• Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR)CompletedNCT02445963Phase 1Results posted
• Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic FeverCompletedNCT02116205Phase 2Results posted
• Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved PlateletsCompletedNCT02078284Phase 1Results posted
• Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused DiarrheaCompletedNCT02067676Phase 1Results posted
• Safety and Tolerability of Antiplaque Chewing Gum in a Gingivitis PopulationCompletedNCT01877421Phase 1/2Results posted
• Evaluation of CL Detect™ Rapid Test to Detect Cutaneous LeishmaniasisCompletedNCT01865032Results posted
• Booster Dose (50 µg) of Recombinant Ricin Toxin Vaccine (RVEc™) in Previously Vaccinated Healthy AdultsCompletedNCT01846104Phase 1Results posted
• A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive ChildrenCompletedNCT01843621Phase 1/2Results posted
• Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in PanamaCompletedNCT01790659Phase 3Results posted
• Evaluation of a Rapid Diagnostic Device, CL Detect, for the Diagnosis of Cutaneous Leishmaniasis in TunisiaCompletedNCT01769612Results posted
• A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy AdultsCompletedNCT01666652Phase 1Results posted
• Safety Study of Chimeric Vaccine to Prevent ETEC DiarrheaCompletedNCT01644565Phase 1Results posted
• mTBI Mechanisms of Action of HBO2 for Persistent Post-Concussive SymptomsCompletedNCT01611194Phase 2Results posted
• Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive AdultsCompletedNCT01540474Phase 1Results posted
• A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous LeishmaniasisCompletedNCT01536795Phase 2Results posted
• WR 279,396 Open Label Treatment Protocol in TunisiaTerminatedNCT01494350Phase 2Results posted
• Safety and Immunogenicity Study of Recombinant Ricin Toxin A-Chain Vaccine (RVEc™)CompletedNCT01317667Phase 1Results posted
• Hyperbaric Oxygen Therapy (HBO2) for Persistent Post-concussive Symptoms After Mild Traumatic Brain Injury (mTBI)CompletedNCT01306968Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in AdultsTerminatedNCT01290601Phase 2Results posted
• Study of VMP001 and AS01B (Adjuvant Formulation) in Healthy Malaria-Naïve AdultsCompletedNCT01157897Phase 1/2Results posted
• Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous LeishmaniasisTerminatedNCT01140191Phase 2Results posted
• Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in PanamaCompletedNCT01083576Phase 2Results posted
• Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine CandidateCompletedNCT01080716Phase 1/2Results posted
• Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)CompletedNCT01032382Phase 2Results posted
• Weekly Dosing of Malarone ® for Prevention of MalariaCompletedNCT00984256Phase 2Results posted
• Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous LeishmaniasisCompletedNCT00884377Phase 2Results posted
• Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old WorldCompletedNCT00703924Phase 2Results posted
• Phase 1 Safety and Immunogenicity of Meningococcal VaccineCompletedNCT00678652Phase 1Results posted
• Sodium Stibogluconate Treatment of LeishmaniasisCompletedNCT00662012Phase 2Results posted
• Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396TerminatedNCT00657917Phase 2Results posted
• Use of Sodium Stibogluconate as a Treatment for LeishmaniasisCompletedNCT00657618Phase 1/2Results posted
• Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)CompletedNCT00606580Phase 3Results posted
• Safety and Immunogenicity Study of a Live Francisella Tularensis VaccineCompletedNCT00584844Phase 2Results posted
• Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) VaccineCompletedNCT00584805Phase 2Results posted
• Safety Evaluation of a Q-fever Vaccine, NDBR 105CompletedNCT00584454Phase 2Results posted
• Safety and Immunogenicity Study of Rift Valley Fever VaccineCompletedNCT00584194Phase 2Results posted
• Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of ProtectionCompletedNCT00485134Phase 1/2Results posted
• A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and ChildrenCompletedNCT00468858Phase 2Results posted
• Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in MaliCompletedNCT00460525Phase 2Results posted
• Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever VaccineCompletedNCT00415051Phase 2Results posted
• NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1CompletedNCT00392015Phase 1/2Results posted
• A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve ChildrenCompletedNCT00384670Phase 1/2Results posted
• A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in ThailandCompletedNCT00370682Phase 2Results posted
• Phase I Pediatric FMP2.1/AS02A Trial in MaliCompletedNCT00358332Phase 1Results posted
• Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US AdultsCompletedNCT00350337Phase 2Results posted
• FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, MaliCompletedNCT00349713Phase 1Results posted
• Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine TrialCompletedNCT00337181Results posted
• A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive InfantsCompletedNCT00322049Phase 1/2Results posted
• Phase 1 Trial of a Malaria Vaccine in Young Kenyan ChildrenCompletedNCT00317473Phase 1Results posted
• Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of AmericaCompletedNCT00312702Phase 1/2Results posted
• Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of AmericaCompletedNCT00312663Phase 1/2Results posted
• Safety Study of Candidate Malaria Vaccine FMP1/AS02A in Healthy Adults in Bandiagara, MaliCompletedNCT00308061Phase 1Results posted
• Safety and Efficacy Study of IV Artesunate to Treat MalariaCompletedNCT00298610Phase 2Results posted
• Study of the Safety of Intravenous ArtesunateCompletedNCT00292942Phase 1Results posted
• Safety and Immunogenicity Study of a Dengue Virus DNA VaccineCompletedNCT00290147Phase 1Results posted
• A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.CompletedNCT00287469Phase 2Results posted
• Comparison of Full-dose Flu Vaccine to Half-dose Flu VaccineCompletedNCT00283283Phase 2Results posted
• Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis.CompletedNCT00248833Phase 1Results posted
• Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria VaccineCompletedNCT00223990Phase 2Results posted
• HIV Vaccine Trial in Thai AdultsCompletedNCT00223080Phase 3Results posted
• Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults.CompletedNCT00197054Phase 2Results posted
• Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy AdultsCompletedNCT05423418Phase 1
• Tecovirimat Intravenous Treatment for Orthopox Virus ExposureNo longer availableNCT05380752
• PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19CompletedNCT04784767Phase 1
• HIV Vaccine in HIV-uninfected AdultsCompletedNCT04658667Phase 1
• Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)No longer availableNCT04360486
• Safety/Immunogenicity Hantaan Virus DNA Vaccine and Puumala Virus DNA Vaccine, For Prevention of HFRSCompletedNCT04333459Phase 2
• Expanded Access Remdesivir (RDV; GS-5734™)No longer availableNCT04302766
• A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy AdultsStatus unknownNCT04296279Phase 1
• Treatment of Hemorrhagic Fever With RibavirinSuspendedNCT04283513Phase 2
• A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy AdultsStatus unknownNCT04268420Phase 1
• A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)WithdrawnNCT04203186Not applicable
• FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4)WithdrawnNCT03867162Phase 2
• Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine CompoundsCompletedNCT03436160Early Phase 1
• Trial to Evaluate the Safety, Immunogenicity, and Efficacy of Malaria Infection in Malaria Naïve AdultsCompletedNCT03341754Phase 1
• Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria ProphylaxisWithdrawnNCT03278808Phase 2
• Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated VaccineStatus unknownNCT03141138Phase 1
• TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B AdjuvantWithdrawnNCT03110952Phase 1
• Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy AdultsStatus unknownNCT03051386Phase 2
• A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA VaccineCompletedNCT02776761Phase 1
• Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) VaccineCompletedNCT02654509Phase 2
• Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young ChildrenCompletedNCT02556996Phase 3
• Evaluation of Weekly TafenoquineCompletedNCT02491606Phase 2
• A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium FalciparumCompletedNCT02488902Phase 2
• Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic FeverSuspendedNCT02483260Not applicable

← U.S. Army Medical Research and Development Command overview and focus areas